Med24
diabetes 18. 9. 2026 • 2 min read • U.S. Food and Drug Administration (OpenFDA)

Venlafaxine Hydrochloride, Extended Release: FDA Clinical Pharmacology, Indications and Prescribing Update

1 INDICATIONS AND USAGE Venlafaxine Hydrochloride Extended-Release Tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1.1 ) Social Anxiety Disorder (SAD) ( 1.2 ) 1.1 Major Depressive Disorder Venlafaxine Hydrochloride Extended-Release Tablets...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Venlafaxine Hydrochloride Extended-Release Tablets are indicated for Major Depressive Disorder (MDD) and Social Anxiety Disorder (SAD), as defined by DSM-IV. Efficacy in MDD was demonstrated in short-term and longer-term trials, with a mean dose of 136 mg/day. SAD treatment efficacy was established in short-term trials. The mechanism of action involves potent inhibition of neuronal serotonin and norepinephrine reuptake, with a weak effect on dopamine reuptake. The drug has no significant affinity for muscarinic cholinergic, H1-histaminergic, or α1-adrenergic receptors. Steady-state concentrations are attained within 3 days, with a linear pharmacokinetic profile. The absolute bioavailability is approximately 45%. Absorption is well-established, with ODV as the major active metabolite. Venlafaxine Hydrochloride Extended-Release Tablets are administered once daily with food, typically starting at 75 mg/day, with potential dose increases up to 225 mg/day for MDD and 75 mg/day for SAD. Clinical studies demonstrated superiority over placebo in MDD across multiple HAM-D measures and CGI scores. In longer-term studies, patients responding to an open-label trial continued on the same dose or switched to placebo for up to 26 weeks, maintaining response. Discontinuation should be gradual and individualized.

Sponsored content

Original Scientific Source
U.S. Food and Drug Administration (OpenFDA)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement